Z-2177-2017 Class II Terminated

Recalled by AbbVie Inc. — North Chicago, IL

FDA device recall Z-2177-2017 was initiated by AbbVie Inc. on Apr 27, 2017 and is designated Class II. Reason for recall: PEG kits have the potential for one of the following defects: missing components, duplicate components or missing label/Instructions for Use, which includes expiry information. The recall status is terminated (terminated Jul 9, 2019).

Recall details

Product Type
Devices
Report Date
Jun 7, 2017
Initiation Date
Apr 27, 2017
Termination Date
Jul 9, 2019
Voluntary/Mandated
Voluntary: Firm initiated

Product description

AbbVie PEG, PEG Kit 15FR, FOR ENTERAL USE ONLY, STERILE, Rx Only.

Reason for recall

PEG kits have the potential for one of the following defects: missing components, duplicate components or missing label/Instructions for Use, which includes expiry information.

Distribution pattern

Nationwide, Albania, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, Great Britain, Greece, Croatia, Hungary, Ireland, Italy, Japan, Korea, Luxembourg, Netherlands, Norway, Portugal, Romania, Russia, Saudi Arabia, Sweden, Slovenia, Slovakia, Turkey

Code information

Material/List number: 629100116 Lots: 32025235, 32184275, 32354106, 32365305, 32435265

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2177-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2177-2017. Report a data issue: hello@regdatalab.com.